Unexpected E. coli response may complicate peptide-based antibiotic combinations
A group of Cornell College students and their professor found surprising results in research on antimicrobial peptides, which are being studied as a method of combating antibiotic resistance. These peptides, part of the innate immune system, could be used to kill bacteria on their own or to create channels for other antibacterial drugs to enter bacteria.
A team of Cornell College students and their professor have discovered an unexpected response from bacteria when exposed to high concentrations of the antimicrobial peptide Magainin 2. Magainin 2 is part of the innate immune system and is being studied as a potential method to combat antibiotic resistance. The researchers found that when E. coli bacteria were exposed to high doses of Magainin 2, the cells became more rigid instead of softer, contrary to previous assumptions.
This discovery contradicts the expectation that the peptide would form pores in the cell wall and make the bacteria more susceptible to additional antibiotics. The team published their findings in the journal Applied Physiology, noting that the biomechanical response of the bacteria to Magainin 2 at high concentrations is a significant factor to consider when developing clinical treatments.
The researchers caution that further investigation is necessary to determine the appropriate concentration-to-drug ratio for Magainin 2 to create an effective therapy for bacterial infections. The study highlights the complexity of developing new treatments against antibiotic-resistant bacteria and the need for continued research in this field.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
